American Cyanamid Co v Ethicon Ltd

American Cyanamid Co v Ethicon Ltd
CC BY-SA 3.0 · source
Name	American Cyanamid Co v Ethicon Ltd
Court	House of Lords
Citation	[1975] AC 396
Judges	Lord Diplock, Lord Simon of Glaisdale, Lord Fraser of Tullybelton, Lord Kilbrandon, Lord Cross of Chelsea
Keywords	interim injunctions, balance of convenience, irreparable harm, patent litigation, interlocutory relief

American Cyanamid Co v Ethicon Ltd A landmark House of Lords decision in 1975 that established the modern test for granting interlocutory injunctions in English law. The case arose from competing patent claims in pharmaceutical and surgical supply markets and set principles widely cited across United Kingdom common-law jurisdictions, influencing judicial approaches in Australia, Canada, New Zealand, and Hong Kong.

Background

The dispute concerned patent rights and product supply between multinational corporations operating in the United States, United Kingdom, and European markets. American Cyanamid Company and Ethicon Ltd litigated over alleged patent infringement relating to surgical materials and associated manufacturing processes. Proceedings moved quickly from trial courts to appellate courts, culminating in an appeal to the House of Lords where five Law Lords heard the matter. The litigation touched on patent enforcement mechanisms under the Patents Act 1977's predecessor arrangements and intersected with commercial remedy doctrines developed in prior cases such as Mareva Compania Naviera SA v International Bulkcarriers SA and statutory frameworks influenced by the Trade Marks Act 1938 era precedents.

Legal Issues

Central questions were whether an interlocutory injunction should be granted to restrain alleged infringement pending trial and what legal standards should guide such a grant. The House of Lords had to determine the role of the plaintiff's prima facie case, the requirement (if any) to prove irreparable harm, and how to evaluate the "balance of convenience" between competing corporate interests. The case also required clarification of interlocutory remedies in the context of intellectual property disputes involving patent validity challenges, cross-border commerce issues implicating European Commission competition concerns, and the potential for undertaking as security for damages in the event of wrongful restraint.

Court Decisions

The House of Lords overturned the approach taken by lower courts and articulated a structured framework for interlocutory relief. The majority, led by judgments from Lord Diplock and supported by Lords Simon, Fraser, Kilbrandon, and Cross, held that courts should not require the plaintiff to demonstrate a strong prima facie case equivalent to trial proof before granting interlocutory relief. Instead, the court identified discrete steps for judicial consideration and remitted aspects to lower courts consistent with that framework. The decision emphasized judicial discretion, practical administration of justice, and coherence with earlier authorities such as Earl of Oxford's case-era equitable principles and more modern precedents.

Reasoning and Legal Tests

The House of Lords set out a tripartite analytical template often summarized as: (1) is there a serious question to be tried?; (2) would damages be an adequate remedy for either party?; and (3) if damages are inadequate, where does the balance of convenience lie? In elaborating this test, the Law Lords rejected rigid formulations requiring proof of irreparable injury in all cases, instead focusing on whether monetary compensation would suffice and, if not, assessing risk allocation by reference to the likely outcome at trial. The decision drew on equitable doctrines associated with remedies articulated in cases involving specific performance and interlocutory relief, and reconciled competing authorities from the Court of Appeal and Chancery Division. The House also discussed undertakings as to damages, security, and the public interest where proprietary rights and competition considerations intersected.

Impact and Significance

The ruling transformed interlocutory injunction jurisprudence across multiple common-law systems. It became a leading authority cited in decisions of the Supreme Court of Canada, the High Court of Australia, the Court of Appeal of England and Wales, and appellate courts in Ireland and Singapore. The "serious question to be tried" and "balance of convenience" formulation influenced subsequent case law on patent enforcement, trade secrets protection, and commercial injunctions, shaping strategic litigation choices by multinational firms such as Roche, GlaxoSmithKline, and Johnson & Johnson. Academic commentary in journals associated with Oxford University, Cambridge University, and Harvard Law School highlighted the decision's pragmatic balance between procedural fairness and substantive rights protection.

Subsequent Developments

Later jurisprudence refined and applied the American Cyanamid principles in contexts including interim freezing orders, anti-suit injunctions, and cross-border intellectual property disputes. Cases such as decisions from the Privy Council, the House of Lords successor, the Supreme Court of the United Kingdom, and appellate bodies in Australia and Canada have clarified issues like evidentiary thresholds, commercial necessity, and public interest exceptions. Legislative developments including reforms to the Civil Procedure Rules and patent litigation procedures in the European Union framework have operated alongside judicial elaborations, but the core American Cyanamid test endures as the starting point for interlocutory injunction applications in common-law jurisdictions.

Category:House of Lords cases Category:Patent law